Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle R Lofwall

Showing results (31-40 of 126) with videos related to

Pageof 13
Sort By:
The International Journal on Drug Policy|May 5, 2019
Impact of health reform on health insurance status among persons who use opioids in eastern Kentucky: A prospective cohort analysisHannah K Knudsen, Michelle R Lofwall, Sharon L Walsh, et al.
The American Journal of Drug and Alcohol Abuse|November 13, 2007
The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenanceWilliam W Stoops, Joshua A Lile, Michelle R Lofwall, et al.
Journal of Substance Abuse Treatment|June 14, 2011
Efficacy of continuing medical education to reduce the risk of buprenorphine diversionMichelle R Lofwall, Martha J Wunsch, Paul A Nuzzo, et al.
Drug and Alcohol Dependence|July 9, 2008
The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusersSharon L Walsh, Paul A Nuzzo, Michelle R Lofwall, et al.
Journal of General Internal Medicine|July 7, 2025
"Medical Cannabis": Advising Patients While Navigating Medical Ethics and Limited EvidenceAnna-Maria South, Shanna L Babalonis, Laura C Fanucchi, et al.
Drug and Alcohol Dependence|March 26, 2016
Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusersSharon L Walsh, Paul A Nuzzo, Shanna Babalonis, et al.
Journal of Addiction Medicine|December 4, 2024
Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical TrialStefan Peterson, Edward V Nunes, Michelle R Lofwall, et al.
JAMA Network Open|June 22, 2019
Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United StatesMinji Sohn, Jeffery C Talbert, Zhengyan Huang, et al.
Addiction Biology|January 21, 2012
Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusersSharon L Walsh, Markus Heilig, Paul A Nuzzo, et al.
Journal of Addiction Medicine|September 16, 2014
Buprenorphine diversion and misuse in outpatient practiceMichelle R Lofwall, Judith Martin, Matt Tierney, et al.
Pageof 13

Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
The International Journal on Drug Policy|May 5, 2019
Impact of health reform on health insurance status among persons who use opioids in eastern Kentucky: A prospective cohort analysisHannah K Knudsen, Michelle R Lofwall, Sharon L Walsh, et al.
The American Journal of Drug and Alcohol Abuse|November 13, 2007
The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenanceWilliam W Stoops, Joshua A Lile, Michelle R Lofwall, et al.
Journal of Substance Abuse Treatment|June 14, 2011
Efficacy of continuing medical education to reduce the risk of buprenorphine diversionMichelle R Lofwall, Martha J Wunsch, Paul A Nuzzo, et al.
Drug and Alcohol Dependence|July 9, 2008
The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusersSharon L Walsh, Paul A Nuzzo, Michelle R Lofwall, et al.
Journal of General Internal Medicine|July 7, 2025
"Medical Cannabis": Advising Patients While Navigating Medical Ethics and Limited EvidenceAnna-Maria South, Shanna L Babalonis, Laura C Fanucchi, et al.
Drug and Alcohol Dependence|March 26, 2016
Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusersSharon L Walsh, Paul A Nuzzo, Shanna Babalonis, et al.
Journal of Addiction Medicine|December 4, 2024
Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical TrialStefan Peterson, Edward V Nunes, Michelle R Lofwall, et al.
JAMA Network Open|June 22, 2019
Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United StatesMinji Sohn, Jeffery C Talbert, Zhengyan Huang, et al.
Addiction Biology|January 21, 2012
Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusersSharon L Walsh, Markus Heilig, Paul A Nuzzo, et al.
Journal of Addiction Medicine|September 16, 2014
Buprenorphine diversion and misuse in outpatient practiceMichelle R Lofwall, Judith Martin, Matt Tierney, et al.
Pageof 13